[go: up one dir, main page]

GB0312845D0 - Use of componds in medicine - Google Patents

Use of componds in medicine

Info

Publication number
GB0312845D0
GB0312845D0 GBGB0312845.1A GB0312845A GB0312845D0 GB 0312845 D0 GB0312845 D0 GB 0312845D0 GB 0312845 A GB0312845 A GB 0312845A GB 0312845 D0 GB0312845 D0 GB 0312845D0
Authority
GB
United Kingdom
Prior art keywords
componds
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0312845.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paradigm Therapeutics Ltd
Original Assignee
Paradigm Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Therapeutics Ltd filed Critical Paradigm Therapeutics Ltd
Priority to GBGB0312845.1A priority Critical patent/GB0312845D0/en
Publication of GB0312845D0 publication Critical patent/GB0312845D0/en
Priority to PCT/GB2004/002298 priority patent/WO2004108119A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0312845.1A 2003-06-04 2003-06-04 Use of componds in medicine Ceased GB0312845D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0312845.1A GB0312845D0 (en) 2003-06-04 2003-06-04 Use of componds in medicine
PCT/GB2004/002298 WO2004108119A2 (en) 2003-06-04 2004-06-01 Use of atp or derivatives in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0312845.1A GB0312845D0 (en) 2003-06-04 2003-06-04 Use of componds in medicine

Publications (1)

Publication Number Publication Date
GB0312845D0 true GB0312845D0 (en) 2003-07-09

Family

ID=9959316

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0312845.1A Ceased GB0312845D0 (en) 2003-06-04 2003-06-04 Use of componds in medicine

Country Status (2)

Country Link
GB (1) GB0312845D0 (en)
WO (1) WO2004108119A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20110576A1 (en) 2011-06-30 2012-12-31 Medicam Health Science S R L COMPOSITION INCLUDING THE ASSOCIATION OF MELISSA PHYTO-EXTRACT, METHYLAMIDE AND A SOURCE OF NUCLEOTIDES AND / OR NUCLEOSIDES AND ITS USE IN THE TREATMENT OF HEADACHE AND HEMICRYANES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049372A (en) * 1982-07-13 1991-09-17 Eliezer Rapaport Anticancer activities in a host by increasing blood and plasma adenosine 5'-triphosphate (ATP) levels
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US6462028B2 (en) * 1997-07-25 2002-10-08 Inspire Pharmaceuticals, Inc. Method of promoting cervical and vaginal secretions
JP2004500013A (en) * 1998-10-16 2004-01-08 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Novel G protein-coupled receptor
EP1337558B1 (en) * 2000-11-07 2010-09-01 Takeda Pharmaceutical Company Limited A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
US6946244B2 (en) * 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
AU2003219664A1 (en) * 2002-01-16 2003-09-02 Eliezer Rapaport Methods and therapeutic compositions in the treatment of advanced cancer

Also Published As

Publication number Publication date
WO2004108119A3 (en) 2005-04-21
WO2004108119A2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
GB0307918D0 (en) Therapeutic use
GB0324761D0 (en) Use of compounds in therapy
IL172316A0 (en) Novel compounds and their use in therapy
EP1682136A4 (en) Therapeutic compounds and uses thereof
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
GB0207410D0 (en) Compounds and their therapeutic use
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
AU2003215767A8 (en) Devices for use in medicine
GB0312845D0 (en) Use of componds in medicine
GB0312844D0 (en) Use of compounds in medicine
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB0301143D0 (en) Compounds and their use
GB0209874D0 (en) Devices for use in medicine
GB0322990D0 (en) Therapeutic use
GB0311457D0 (en) New therapeutic use
GB0310251D0 (en) Therapeutic methods and compositions for use therein
GB0326870D0 (en) Therapeutic methods and compositions for use therein
GB0302801D0 (en) Therapeutic methods and compositions for use therein
GB0303165D0 (en) Therapeutic methods and compositions for use therein
GB0312822D0 (en) Triazolo-pyrimidine compounds and their use in medicine
GB0302933D0 (en) Compounds and their use
GB0309319D0 (en) Compounds and their use
GB0301147D0 (en) Compounds and their use
GB0302930D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)